Vyome Holdings, Inc. (HIND) Estados Financieros e Histórico

Vyome Holdings, Inc. (HIND) — Precio $2.10 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Vyome Holdings, Inc. (HIND): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Vyome Holdings, Inc. registró ingresos de $319714 en el último ejercicio fiscal, con un CAGR de 5 años del -51.0%.

Márgenes de los últimos 12 meses: margen bruto 46.5%, margen operativo -32.5%, margen neto -87.2%.

Al precio actual de $2.10, HIND presenta beneficios negativos (P/E no significativo) y un ROE del -254.62%. La capitalización bursátil es de $15M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$786660$1.3M$606710$15.1M$11.3M$13.6M$11.2M$8.7M$8.0M$319714
Coste de Ventas$431476$936386$164299$5.8M$5.0M$5.3M$4.4M$3.1M$2.9M$112928
Beneficio Bruto$355184$350768$442411$9.3M$6.3M$8.3M$6.8M$5.5M$5.1M$206786
I+D$5.2M$5.8M$5.7M$3.1M$3.5M$2.4M$2.5M$2.3M$1.8M$588258
Generales y Administrativos$18.0M$26.0M$19.3M$22.1M$15.2M$33.2M$31.3M$17.9M$9.9M$2.4M
Gastos Operativos$23.2M$31.8M$25.0M$33.8M$18.7M$66.2M$33.9M$20.2M$12.8M$3.0M
Beneficio Operativo-$22.8M-$31.4M-$38.5M-$24.5M-$12.5M-$57.9M-$27.1M-$14.6M-$7.7M-$2.7M
EBITDA-$19.5M-$34.4M-$37.0M-$72.9M-$18.1M-$60.6M-$44.3M-$11.2M-$6.6M-$10.3M
Gastos por Intereses$4.1M$3874$12000$451000$2.0M$832000$11300000$146641
Beneficio Antes de Impuestos-$23.4M-$36.1M-$38.7M-$75.1M-$21.8M-$63.4M-$46.6M-$11.3M-$7.1M-$10.5M
Impuestos0-$2.3M-$3.4M-$893000-$181000-$274000-$380000$52000$390000
Beneficio Neto-$23.4M-$33.8M-$81.2M-$74.2M-$21.6M-$63.1M-$46.2M-$11.4M-$7.1M-$10.3M
BPA$-10548750.00$-4524000.00$-4270786.00$-1094068.00$-503023.26$-419004.00$-157897.00$-2771.94$-345.74$-4.75
BPA Diluido$-10548750.00$-4524000.00$-4270786.00$-1094068.00$-503023.26$-419004.00$-157897.00$-2771.94$-345.74$-4.75
Acciones en Circulación (Diluidas)0$8$9$22$43$151$293$4107$20622$2.2M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$34627$36551$31591$26955
Beneficio Bruto$15244$19378$14040$11658
Beneficio Operativo-$868777-$1.4M-$1.1M-$862566
EBITDA-$8.6M-$1.3M-$980071-$713748
Beneficio Neto-$8.4M-$1.2M-$962910-$685556
BPA$-29.42$-0.21$-0.17$-0.10
BPA Diluido$-29.42$-0.21$-0.17$-0.10

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$3.3M$10.2M$5.5M$2.9M$3.0M$22.8M$4.0M$4.6M$693000$5.0M
Inversiones a Corto$2.5M$23.3M00000000
Cuentas por Cobrar$143692$488613$917000$4.1M$2.6M$2.8M$2.2M$1.7M$1.0M$98611
Inventario$1.8M$2.8M$984735$1.3M$2.2M$3.0M$3.6M$3.7M$2.5M0
Activos Corrientes$5.7M$13.9M$8.7M$10.1M$8.9M$29.9M$9.9M$10.3M$4.6M$5.4M
Inmovilizado Material$201000$439000$63548$774000$1.0M$1.7M$869000$310000$154000$75821
Fondo de Comercio0$27.2M00000000
Activos Intangibles0$46.2M$36.9M$28.7M$27.0M$20.8M$26000000$314191
Activos Totales$7.0M$88.7M$46.3M$39.7M$39.7M$52.5M$11.3M$10.7M$4.8M$6.5M
Cuentas por Pagar$1.3M$1.1M$1.6M$4.3M$3.7M$3.5M$1.9M$1.7M$2.2M$647533
Deuda a Corto0$2.0M$9.9M$1.9M$3.9M0$171000$111000$811000$31258
Pasivos Corrientes$1.3M$1.1M$8.4M$10.4M$11.6M$7.5M$7.5M$3.8M$5.0M$2.7M
Deuda a Largo$9.9M$8.0M0$2.7M$9.2M00000
Pasivos Totales$4.1M$12.3M$14.6M$15.5M$25.2M$8.2M$7.6M$4.1M$5.0M$2.7M
Reservas-$300.9M-$334.8M-$419.0M-$493.2M-$514.8M-$578.0M-$624.2M-$635.6M-$642.7M-$87.6M
Patrimonio Neto$2.9M$76.4M$31.7M$24.1M$14.5M$44.3M$3.7M$6.7M-$253000$2.4M
Deuda Total$143692$488613$6.3M$5.4M$13.3M$279000$171000$262000$967000$31258
Deuda Neta-$3.2M-$9.7M$762465$2.5M$10.2M-$22.5M-$3.8M-$4.3M$274000-$5.0M
Capital Circulante$4.4M$12.8M$356492-$280000-$2.7M$22.4M$2.4M$6.5M-$397000$2.7M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$5.7M$5.0M$8.8M$7.9M
Activos Totales$7.0M$6.5M$10.2M$9.2M
Pasivos Totales$3.1M$2.7M$2.1M$1.9M
Patrimonio Neto$2.5M$2.4M$6.7M$6.0M
Deuda Total$38609$31258$22548$17310

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$23.4M-$33.8M-$35.3M-$74.2M-$21.6M-$35.5M-$46.2M-$11.4M-$7.1M-$10.5M
Amortizaciones$139576$925463$440557$1.7M$1.7M$2.0M$2.2M$154000$22000$11985
Compensación en Acciones$2.3M$4.4M$3.1M$2.3M$1.3M$12.2M$2.1M$766000$184000$6.6M
Cambio en Capital Circulante$1.9M$1.4M$857216-$1.4M$6000-$2.7M$709000-$4.1M$2.3M$39905
Flujo de Caja Operativo-$20.7M-$24.6M-$27.5M-$14.2M-$8.6M-$15.4M-$21.9M-$17.0M-$4.4M-$3.7M
Inversiones (CapEx)-$14000-$137123-$49579-$14000-$390000-$352000-$131000-$4300000
Adquisiciones0-$6.2M-$10.3M-$2.0M-$2.0M$2.2M$39000000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$20.7M-$24.7M-$27.5M-$14.2M-$8.9M-$15.7M-$22.0M-$17.0M-$4.4M-$3.7M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$4.3M-$1.5M-$1.4M-$903712
Inversiones (CapEx)-$50$40
Flujo de Caja Libre$4.3M-$1.5M-$1.4M-$903712
Dividendos Pagados0000
Compensación en Acciones0$1030190$11051

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+63.6%-52.9%+2387.0%-25.1%+20.4%-17.4%-22.8%-7.7%-96.0%
Crecimiento Beneficio Neto (anual)-44.8%-140.0%+8.6%+70.9%-191.9%+26.8%+75.4%+37.4%-43.9%
Crecimiento BPA (anual)+57.1%+5.6%+74.4%+54.0%+16.7%+62.3%+98.2%+87.5%+98.6%
Cambio en Acciones (anual)+13.9%+147.2%+98.7%+250.5%+94.2%+1303.2%+402.1%+10380.8%
Crecimiento FCF (anual)-19.6%-11.4%+48.4%+37.1%-75.9%-40.1%+22.8%+74.0%+15.3%
Margen Bruto45.2%27.3%72.9%61.7%55.4%61.4%60.5%63.9%63.2%64.7%
Margen Operativo-2897.8%-2440.1%-6353.3%-162.1%-110.2%-425.6%-240.9%-168.7%-96.5%-859.2%
Margen EBITDA-2479.5%-2671.9%-6092.7%-483.4%-160.1%-445.7%-394.4%-128.8%-83.0%-3227.6%
Margen Neto-2969.6%-2627.3%-13375.7%-491.8%-191.4%-464.3%-411.2%-131.2%-89.1%-3209.7%
Margen FCF-2627.5%-1920.9%-4539.2%-94.2%-79.1%-115.6%-196.0%-195.9%-55.3%-1172.6%
Tasa Impositiva Efectiva-0.0%6.4%8.9%1.2%0.8%0.4%0.8%-0.5%-0.5%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-3216918.36$-3146500.89$-656828.87$-207906.98$-104356.31$-75279.46$-4140.00$-214.67$-1.73
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)0$8$9$22$43$151$293$4107$20622$2.2M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-254.62%
Rentabilidad sobre capital invertido-57.53%
Rentabilidad sobre activos-123.23%
Margen bruto46.50%
Margen operativo-3250.25%
Margen neto-8716.77%

Salud financiera

Deuda / Patrimonio0.00
Ratio corriente4.37
Piotroski F-Score3
Altman Z-Score-18.08

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-7.30-12.71-4.22-1.51-2.59-1.14-0.25-0.52-1.29-0.72
P/VC0.005.794.981.483.871.623.130.89-36.353.04
P/V0.00343.39259.802.374.975.271.020.691.1523.26
Margen Bruto45.2%27.3%72.9%61.7%55.4%61.4%60.5%63.9%63.2%64.7%
Margen Operativo-2897.8%-2440.1%-6353.3%-162.1%-110.2%-425.6%-240.9%-168.7%-96.5%-859.2%
Margen Neto-2969.6%-2627.3%-13375.7%-491.8%-191.4%-464.3%-411.2%-131.2%-89.1%-3209.7%

Empresas relacionadas: ARMP · CCCC · CDXS · CGEN · IMDX · IPHA · NVCT

Explorar sector: Healthcare · Biotechnology

Más secciones de HIND: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones